Condition Guide

Life Insurance with Diabetes: What Underwriters Actually Look At

The Type 1 versus Type 2 distinction matters less than most people think. What shifts the underwriting picture is what the condition has produced: complications, treatment trajectory, and a handful of specific flags that signal active change.

CH
Claire Haddon Senior Editor, KnowYourPolicy.ca
Reviewed by a licensed Canadian insurance professional
The information on this page describes how Canadian life insurers generally assess this condition. It is not a coverage assessment for your specific situation. Eligibility depends on your individual health history, the insurer's current underwriting guidelines, and the type of policy you apply for. A licensed advisor can give you an accurate picture.

The assumption going into this search is usually wrong in the same direction.

Young diagnosis. Long history. Type 1 on the form. And somewhere along the way, the conclusion formed that options would be limited, that the conversation probably wasn't worth having.

The diagnosis age matters less than what happened after it.

What underwriters are looking at when someone with a long history of diabetes applies isn't the number on the form. The questions they're asking, through the health questionnaire rather than a medical exam, are about what the condition has or hasn't produced in the years since diagnosis. Complications. Treatment trajectory. Whether anything is currently under active investigation. Whether daily life has been affected.

For a reader who has managed their condition for twenty or thirty years with stable treatment and nothing else in the picture, that track record is something an underwriter can see. Not a liability. A record.

What the application is actually asking about

Simplified issue life insurance, coverage that replaces the medical exam with a set of health questions answered by the applicant, doesn't ask which type of diabetes you have on most Canadian products. The questions are more specific, and more useful, than that.

The variables that actually shift what's available: whether insulin is involved and whether the regimen has been stable, whether any complications have developed, whether there are upcoming appointments with specialists, whether help is needed with daily tasks, and whether there has been a recent hospitalization. Those are the gates. The type label isn't one of them.

A reader with Type 1 diabetes diagnosed at nineteen, now forty-four, on a stable insulin regimen with no cardiovascular involvement and no kidney or nerve complications, may answer those questions very differently than someone with a recent diagnosis that arrived alongside a cardiac event and a referral to a kidney specialist. Same category of condition. Very different underwriting picture.

The complication hierarchy

Not every complication carries equal weight. The picture shifts in degrees, depending on which system is involved.

Where diabetes meets cardiac history is where the picture tightens most. Coronary involvement, a cardiac event in the history, peripheral vascular disease (reduced circulation in the arteries): these carry significant weight. The combination of diabetes and heart disease is the area where the underwriting conversation becomes most complex.

Kidney involvement, including nephropathy (kidney damage), reduced function, and protein in the urine, is the other area that tends to close the simplified issue door most consistently. Renal complications signal systemic progression in a way that affects how most simplified issue products respond to the health questions.

Neuropathy (nerve damage) and retinopathy (eye involvement) are meaningful, but stable and actively monitored, they add complexity without necessarily changing the outcome entirely. An advisor who has worked with these combinations knows which products ask which questions and how a stable, documented complication is likely to land.

Complications that suggest active systemic progression, or that involve the cardiac or renal system, shift the picture most. Complications that are stable, documented, and being managed are a different conversation than ones that are new or still changing.

The flags that signal active change

Beyond complications, a few things tend to signal active change rather than stable management. Active change is what simplified issue underwriting is most cautious about.

Upcoming appointments with specialists. A cardiology appointment, a nephrology referral, an endocrinology assessment for investigation rather than routine review: these signal that something is under active assessment. The outcome of that appointment isn't known yet. An underwriter writing a policy today is writing it without knowing what that appointment will find.

Help with daily tasks. If complications have reached the point where assistance is needed with day-to-day activities, that shifts what products are available.

Recent hospitalization. A hospital stay in the last few months, related to diabetes or its complications, signals an acute event that may still be resolving. Most simplified issue products ask about this directly.

None of these are permanent closures. A specialist appointment concludes, results come in, the picture clarifies. A reader in that window right now may find it worth waiting until things settle before starting an application.

The long track record

Thirty years of stable management is thirty years of evidence.

An underwriter looking at someone now in their fifties, diagnosed young, with a decades-long record of controlled treatment and nothing else in the picture: no cardiovascular involvement, no renal complications, stable regimen for years. The underwriter can see what that duration produced. Duration with stable management gives the underwriter something to work with. That visibility works in the applicant's favour when the record is clean.

The assumption that young diagnosis automatically means a worse outcome gets the logic backwards in cases like this. A recent diagnosis with an unsettled treatment picture is a different conversation than a long one with a clean record.

Where early diagnosis does add complexity is when it arrives alongside complications that have had longer to develop. Long duration with cardiovascular involvement, or with progressing kidney function, carries more weight than long duration without those factors. The diagnosis age and the complication picture aren't independent of each other.

Term is worth asking about

Most people with a long history of diabetes assume simplified issue whole life is the ceiling. It often isn't.

Term life insurance, coverage for a defined period, usually ten, twenty, or thirty years, may be available to a reader with well-controlled diabetes, stable treatment, and no significant complications. The premium is higher than for a reader without the condition, the coverage available per dollar is substantially larger than simplified issue whole life, and for a reader who still has a mortgage, a spouse who hasn't reached pension age, or income others depend on, the coverage need may call for term rather than a smaller permanent policy.

The BOM framework is useful here. Burden: what gets left behind immediately, the mortgage balance, debts, final expenses. Obligations: what still needs to be paid each month, income replacement, a spouse whose pension hasn't started. Milestone: when that financial exposure starts to drop, when the mortgage clears, when the pension commences. A reader with significant burden and obligations still in play is in a different coverage conversation than one whose financial exposure is behind them.

For a reader in that first group, obligations still active and milestone still ahead, term is the product worth exploring first. An advisor runs both numbers. A twenty-year term policy at a higher-than-standard premium may still produce significantly more coverage per dollar than a simplified issue whole life policy at a lower one.

And term policies in Canada often include a conversion option: the right to convert to permanent coverage later, without new medical evidence, based on the health status at the time the policy was issued. For someone whose condition is well-controlled now but whose picture may change in fifteen years, that conversion right has real value. It locks in access to permanent coverage later. Not the rate. The access.

Not every term product includes a conversion privilege. Before any application is submitted, confirm in writing that the specific policy includes it. Some lower-premium products are missing that feature, and it matters more later than it does at issue.

Guaranteed Acceptance: The Floor That Doesn't Close

When the health questions on simplified issue produce answers that affect eligibility, complications present, recent hospitalization, active specialist investigation, guaranteed acceptance life insurance is the next door. And it doesn't close.

No health questions. Acceptance guaranteed within the eligible age range. The policy is issued on age and premium, not health history.

The term to understand is the two-year waiting period for non-accidental death. During the first two years, if the insured dies of illness, the beneficiary receives the premiums paid plus interest rather than the face amount. After two years, the full benefit is in force. Accidental death is typically covered from day one, though exact terms vary by product and should be confirmed in the policy document.

Coverage under guaranteed acceptance is sized for final expenses. A reader still carrying significant obligations will want to know whether simplified issue or term is available first. The advisor runs both.

What's actually useful to bring to the conversation

The most useful inputs aren't a coverage number and a product preference. The coverage number named before the conversation tends to become a ceiling that's hard to move past.

What's useful: knowing what obligations are still in play. A mortgage balance and how many years remain. Whether a spouse is still a decade away from pension. Whether income is being replaced for someone who depends on it. What monthly premium feels completely manageable regardless of what happens next.

Those inputs let an advisor map what's realistically available to what's actually needed.

A reader with a long history of well-managed diabetes is often surprised by what that conversation produces. The assumption going in, that options would be limited, that the conversation wasn't worth having, tends to be more cautious than the outcome.